The first look that tells you what to do next. A 15-minute MRI exam, a quantitative report, and the confidence of a biomarker the literature has been building for fourteen years.
Quantitative MRI delivers a report your clinical team can act on the same day, no biopsy, no waiting list, no ambiguity. It is a diagnostic aid that extends your judgment, not a tool that replaces it.
15-minute non-contrast MRI on any 1.5T or 3T scanner already in your radiology department. No injection, no fasting protocol.
Color-mapped tissue characterization overlaid on the anatomy. cT1, PDFF, and iron, quantified per voxel, not estimated.
A single-page report your hepatologist, radiologist, or MDT can read in 60 seconds. Treat, monitor, or refer, with the evidence to back it.
The same clinical promise, said the way each audience needs to hear it. These are concept lines under review; the segment structure is still being set.
Spot active liver disease a fibrosis score can miss, and know who to refer now.
See whether the liver is responding to treatment, not just the number on the scale.
When fibrosis stage does not tell the whole story, measure the disease activity.
Add quantitative liver analysis across your fleet. No new hardware, no contrast.
Give members a quantitative read on liver and metabolic health they can track year on year.
See what is happening inside your liver. One MRI, no needle, answers you can act on.
Fewer unnecessary biopsies and referrals, with cost-effectiveness shown in a randomized trial.
Concept lines, derived from internal clinical messaging. Each passes the claims matrix before any production use.
Five quantitative imaging products, each read from a standard MRI. Jump to the one that fits the patient in front of you.
cT1 and PDFF from a single MRI sequence, quantitative and repeatable, to triage and monitor MASLD without tissue.
A multi-organ MRI assessment for post-viral, post-cancer and complex multi-system patients, in a single appointment.
Quantitative MRCP to diagnose and follow biliary patients without diagnostic ERCP.
Couinaud-aware liver assessment and future liver remnant, presented as a brief the surgical team can act on.
MRI quantification of fat, muscle and visceral compartments for metabolic and obesity care.
What the report looks like, by condition.
A 47-year-old patient referred for unexplained liver enzyme elevations. Two biopsies came back inconclusive. A 15-minute LiverMultiScan flagged elevated cT1 across segments IV, VII and VIII, referred to a specialist hepatology MDT and on treatment within three weeks.
Recognized in US hepatology, gastroenterology and endocrinology guidelines, plus the European EASL-EASD-EASO MASLD guidelines. AACE engagement in progress.
Cloud-delivered. No new hardware. Site activation in two weeks, not six months.
1.5T and 3T MRI from any major vendor. Sequences ship to us via cloud, reports come back the same way.
Site training, IT integration, and first patient scan, all inside two weeks. Onboarding led by our clinical implementation team.
One-page, color-coded, MDT-friendly. Available via DICOM PACS integration or our standalone Portal.
Talk to our clinical adoption team. We'll get back to you inside two working days with the right introduction.
